Small Pharma Inc. (DMTTF)
| Previous Close | 0.1210 |
| Open | 0.1256 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.1135 - 0.1258 |
| 52 Week Range | 0.0600 - 0.9700 |
| Volume | |
| Avg. Volume | 44,537 |
| Market Cap | 36.07M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1370 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Small Pharma Shares Business Update Ahead of Annual Financial Results
- Appointment of Alastair Riddell as COO- Two new Composition of Matter patents granted for pipeline projects- Progress continues across short-acting psychedelics portfolio LONDON, May 25, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, provides a business update ahead of its annual financial results for the fiscal year ended Februa
- GlobeNewswire
Small Pharma to Participate in the PSYCH Symposium: London 2022
Conference to take place at The National Gallery in London on May 11, 2022LONDON, May 05, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, will participate in the PSYCH Symposium: London 2022 – Shaping The Future Of Psychedelic Healthcare. Dr. Carol Routledge, Small Pharma’s Chief Medical and Scientific Officer, will join a panel dis
- GlobeNewswire
KCSA Psychedelics Virtual Investor Conference Presentations Now Available for On-Demand Viewing
NEW YORK, April 29, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the April 27th and 28th KCSA Psychedelics Virtual Investor Conference are now available for on-demand viewing. REGISTER OR LOGIN NOW AT: https://bit.ly/3OGHgD4 The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company’s resource section. Comp
